SINGAPORE HEALTH SERVICES PTE has a total of 11 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are MEDIZINISCHE UNIVERSITÄT GRAZ, ST VINCENTS HOSPITAL SYDNEY LTD and NARAIN NIVEN RAJIN.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 2 | |
#3 | China | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Environmental technology | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Tan Donald | 3 |
#2 | Zhou Lei | 3 |
#3 | Liu Shouping | 3 |
#4 | Beuerman Roger | 3 |
#5 | Suresh Anita | 2 |
#6 | Li Jing | 2 |
#7 | Verma Chandra Shekhar | 2 |
#8 | Hui Kam Man | 2 |
#9 | Xiao Zhi Cheng | 1 |
#10 | Ng Tze Kiat | 1 |
Publication | Filing date | Title |
---|---|---|
SG151148A1 | Method and/or kit for determining response to muscarinic receptor antagonist treatment | |
WO2008027017A1 | Modulation of neural activity and/or condition | |
WO2007126391A1 | Investigation of mucosa dryness conditions | |
WO2007058623A1 | Methods of predicting hepatocellular carcinoma recurrence by the determination of hepatocellular carcinoma recurrence-associated molecular biomarkers |